These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 7585241)
1. Reliability of visual acuity measurements and screening under field conditions. Hawkins BS Ophthalmic Epidemiol; 1995 Jun; 2(2):99-106. PubMed ID: 7585241 [TBL] [Abstract][Full Text] [Related]
2. Risk of visual impairment attributable to ocular histoplasmosis. Washington County Follow-up Eye Study Group. Hawkins BS; Ganley JP Arch Ophthalmol; 1994 May; 112(5):655-66. PubMed ID: 8185524 [TBL] [Abstract][Full Text] [Related]
3. Five-year follow-up of fellow eyes of individuals with ocular histoplasmosis and unilateral extrafoveal or juxtafoveal choroidal neovascularization. Macular Photocoagulation Study Group. Arch Ophthalmol; 1996 Jun; 114(6):677-88. PubMed ID: 8639078 [TBL] [Abstract][Full Text] [Related]
4. Qualifying to Use a Home Monitoring Device for Detection of Neovascular Age-Related Macular Degeneration. Thomas M; Wolfson Y; Zayit-Soudry S; Bressler SB; Bressler NM JAMA Ophthalmol; 2015 Dec; 133(12):1425-30. PubMed ID: 26468999 [TBL] [Abstract][Full Text] [Related]
5. A comprehensive assessment of visual impairment in a population of older Americans. The SEE Study. Salisbury Eye Evaluation Project. Rubin GS; West SK; Muñoz B; Bandeen-Roche K; Zeger S; Schein O; Fried LP Invest Ophthalmol Vis Sci; 1997 Mar; 38(3):557-68. PubMed ID: 9071208 [TBL] [Abstract][Full Text] [Related]
6. Responsiveness of the National Eye Institute Visual Function Questionnaire to changes in visual acuity: findings in patients with subfoveal choroidal neovascularization--SST Report No. 1. Miskala PH; Hawkins BS; Mangione CM; Bass EB; Bressler NM; Dong LM; Marsh MJ; McCaffrey LD; Arch Ophthalmol; 2003 Apr; 121(4):531-9. PubMed ID: 12695250 [TBL] [Abstract][Full Text] [Related]
7. Laser photocoagulation for juxtafoveal choroidal neovascularization. Five-year results from randomized clinical trials. Macular Photocoagulation Study Group. Arch Ophthalmol; 1994 Apr; 112(4):500-9. PubMed ID: 7512336 [TBL] [Abstract][Full Text] [Related]
8. Photodynamic therapy with verteporfin in ocular histoplasmosis: uncontrolled, open-label 2-year study. Rosenfeld PJ; Saperstein DA; Bressler NM; Reaves TA; Sickenberg M; Rosa RH; Sternberg P; Aaberg TM; Aaberg TM; Ophthalmology; 2004 Sep; 111(9):1725-33. PubMed ID: 15350329 [TBL] [Abstract][Full Text] [Related]
9. Photodynamic therapy of subfoveal choroidal neovascularization with verteporfin in the ocular histoplasmosis syndrome: one-year results of an uncontrolled, prospective case series. Saperstein DA; Rosenfeld PJ; Bressler NM; Rosa RH; Sickenberg M; Sternberg P; Aaberg TM; Aaberg TM; Reaves TA; Ophthalmology; 2002 Aug; 109(8):1499-505. PubMed ID: 12153802 [TBL] [Abstract][Full Text] [Related]
10. Changes in visual acuity in a population. The Beaver Dam Eye Study. Klein R; Klein BE; Lee KE Ophthalmology; 1996 Aug; 103(8):1169-78. PubMed ID: 8764783 [TBL] [Abstract][Full Text] [Related]
11. Reproducibility of refraction and visual acuity measurement under a standard protocol. The Macular Photocoagulation Study Group. Blackhurst DW; Maguire MG Retina; 1989; 9(3):163-9. PubMed ID: 2480626 [TBL] [Abstract][Full Text] [Related]
12. Surgical removal vs observation for subfoveal choroidal neovascularization, either associated with the ocular histoplasmosis syndrome or idiopathic: I. Ophthalmic findings from a randomized clinical trial: Submacular Surgery Trials (SST) Group H Trial: SST Report No. 9. Hawkins BS; Bressler NM; Bressler SB; Davidorf FH; Hoskins JC; Marsh MJ; Miskala PH; Redford M; Sternberg P; Thomas MA; Toth CA; Arch Ophthalmol; 2004 Nov; 122(11):1597-611. PubMed ID: 15534121 [TBL] [Abstract][Full Text] [Related]
13. Reliability of visual acuity in children with reduced vision. Kheterpal S; Jones HS; Auld R; Moseley MJ Ophthalmic Physiol Opt; 1996 Sep; 16(5):447-9. PubMed ID: 8944189 [TBL] [Abstract][Full Text] [Related]
14. Objective measurement of visual acuity by optokinetic response determination in patients with ocular diseases. Shin YJ; Park KH; Hwang JM; Wee WR; Lee JH; Lee IB Am J Ophthalmol; 2006 Feb; 141(2):327-32. PubMed ID: 16458689 [TBL] [Abstract][Full Text] [Related]
15. Associations of visual function with physical outcomes and limitations 5 years later in an older population: the Beaver Dam eye study. Klein BE; Moss SE; Klein R; Lee KE; Cruickshanks KJ Ophthalmology; 2003 Apr; 110(4):644-50. PubMed ID: 12689880 [TBL] [Abstract][Full Text] [Related]
16. Detection of early visual impairment in patients with epiretinal membrane. Nishi Y; Shinoda H; Uchida A; Koto T; Mochimaru H; Nagai N; Tsubota K; Ozawa Y Acta Ophthalmol; 2013 Aug; 91(5):e353-7. PubMed ID: 23387556 [TBL] [Abstract][Full Text] [Related]
17. Five-year change in visual acuity and incidence of visual impairment: the Blue Mountains Eye Study. Foran S; Mitchell P; Wang JJ Ophthalmology; 2003 Jan; 110(1):41-50. PubMed ID: 12511344 [TBL] [Abstract][Full Text] [Related]
18. Repeatability and Agreement of Visual Acuity Using the ETDRS Number Chart, Landolt C Chart, or ETDRS Alphabet Chart in Eyes With or Without Sight-Threatening Diseases. Chaikitmongkol V; Nanegrungsunk O; Patikulsila D; Ruamviboonsuk P; Bressler NM JAMA Ophthalmol; 2018 Mar; 136(3):286-290. PubMed ID: 29346499 [TBL] [Abstract][Full Text] [Related]
19. Assessment of visual acuity via a telephone interview. DeiCas R; Street DA; Javitt JC Arch Ophthalmol; 1992 Sep; 110(9):1279-82. PubMed ID: 1520117 [TBL] [Abstract][Full Text] [Related]
20. Reading performance in patients with retinitis pigmentosa: a study using the MNREAD charts. Virgili G; Pierrottet C; Parmeggiani F; Pennino M; Giacomelli G; Steindler P; Menchini U; Orzalesi N; Invest Ophthalmol Vis Sci; 2004 Oct; 45(10):3418-24. PubMed ID: 15452044 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]